People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathwork Diagnostics Inc | — | Biotechnology | Series B | $52.5M | $1.0B | 2010 |
Greg J. Lahann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Greg J. Lahann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James B. Tananbaum | 1 | 4 |
| Deborah J. Neff | 1 | 2 |
| Richard J. Bastiani | 1 | 2 |
| Shahzad J. Malik | 1 | 2 |
| Fletcher J. Payne | 1 | 1 |
| Ken J. Haas | 1 | 1 |
| Rick J. Klausner | 1 | 1 |
| David B. Mack | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.